NEO Neogenomics Inc

NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida; Irvine, California and Nashville, and Tennessee.

$11.64  +0.47 (4.21%)
As of 12/02/2022 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  01/23/2001
Outstanding shares:  126,303,261
Average volume:  1,351,570
Market cap:   $1,410,807,425
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2598246
Valuation   (See tab for details)
PE ratio:   -41.18
PB ratio:   1.35
PS ratio:   2.90
Return on equity:   -3.32%
Net income %:   -7.33%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy